In The News

High Court Boosts Biosimilars By Allowing Early Notice


12 Jun 2017
Reprinted with permission.

The Law360 article “High Court Boosts Biosimilars By Allowing Early Notice” dissects the major victory for partner Deanne E. Maynard in which the Supreme Court agreed unanimously with Sandoz that the Federal Circuit had erred by delaying introduction of all biosimilars by 180 days.

Read the full article.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.